Do epithelial mutations and exhausted t cells conspire to create a tumor prone niche for endometriosis associated ovarian cancer development

Active Project Grant Awarded Last action

Award ID
HT9425261E122
Recipient
Awarding agency
Obligated
$700,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 12% complete
Place of performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded The University of British Columbia $700,000 on May 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate epithelial mutations and exhausted T cells in endometriosis-associated ovarian cancer development.

The research is performed at 2323 Riverside Drive, Ottawa, Ontario, Canada, with a performance period extending through April 30, 2030. The University of British Columbia, operating as Research Services, serves as the prime recipient of this project grant.

Quick answers

Who received award HT9425261E122?

HT9425261E122 was awarded to The University Of British Columbia by Defense Health Agency (Department of Defense) on May 1, 2026.

How much is award HT9425261E122 worth?

$700,000 has been obligated on HT9425261E122.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login